BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 8058238)

  • 1. Prognostic significance of malignant cervical cytology in patients with endometrial cancer.
    Larson DM; Johnson KK; Reyes CN; Broste SK
    Obstet Gynecol; 1994 Sep; 84(3):399-403. PubMed ID: 8058238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of gross myometrial invasion with endometrial cancer.
    Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
    Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic and para-aortic lymphadenectomy for surgical staging of high-risk endometrioid adenocarcinoma of the endometrium.
    Larson DM; Johnson KK
    Gynecol Oncol; 1993 Dec; 51(3):345-8. PubMed ID: 8112643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance.
    Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H; Yamasaki F
    Gynecol Oncol; 1999 Mar; 72(3):273-7. PubMed ID: 10053095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.
    Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT
    Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
    Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
    Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical staging for patients presenting with grade 1 endometrial carcinoma.
    Ben-Shachar I; Pavelka J; Cohn DE; Copeland LJ; Ramirez N; Manolitsas T; Fowler JM
    Obstet Gynecol; 2005 Mar; 105(3):487-93. PubMed ID: 15738013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial carcinoma: the relevance of cervical cytology.
    DuBeshter B; Warshal DP; Angel C; Dvoretsky PM; Lin JY; Raubertas RF
    Obstet Gynecol; 1991 Mar; 77(3):458-62. PubMed ID: 1992417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.
    Fotopoulou C; Savvatis K; Kraetschell R; Schefold JC; Lichtenegger W; Sehouli J
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):199-203. PubMed ID: 20096987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients.
    Mariani A; Dowdy SC; Cliby WA; Haddock MG; Keeney GL; Lesnick TG; Podratz KC
    Gynecol Oncol; 2006 May; 101(2):200-8. PubMed ID: 16510174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma.
    Ayhan A; Bozdag G; Taskiran C; Gultekin M; Yuce K; Kucukali T
    Gynecol Oncol; 2006 Dec; 103(3):902-5. PubMed ID: 16828847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The comparison of clinical and surgical-pathological staging for endometrial carcinoma].
    Peng Z; Liu X; Zhang J
    Zhonghua Fu Chan Ke Za Zhi; 1997 Oct; 32(10):597-600. PubMed ID: 9642375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
    Fujimoto T; Nanjyo H; Nakamura A; Yokoyama Y; Takano T; Shoji T; Nakahara K; Yamada H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
    Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical predictors of para-aortic metastases in early-stage cervical carcinoma.
    Hackett TE; Olt G; Sorosky JI; Podczaski E; Harrison TA; Mortel R
    Gynecol Oncol; 1995 Oct; 59(1):15-9. PubMed ID: 7557602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of DNA ploidy in endometrial cancer.
    Larson DM; Berg R; Shaw G; Krawisz BR
    Gynecol Oncol; 1999 Sep; 74(3):356-60. PubMed ID: 10479493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-stage cervical adenocarcinoma treated by surgical intent: the role of para-aortic lymph node dissection.
    Lea JS; Sheets EE; Duska LR; Miller DS; Schorge JO
    Gynecol Oncol; 2002 Feb; 84(2):285-8. PubMed ID: 11812088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of routine lymphadenectomy in clinical stage-I endometrial cancer.
    Han SS; Cho JY; Park IA; Park SK; Jeon YT; Kim JW; Park NH; Kang SB; Lee HP; Song YS
    Med Sci Monit; 2008 Apr; 14(4):CR183-9. PubMed ID: 18376345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial carcinoma: analysis of recurrence in patients treated with a strategy minimizing lymph node sampling and radiation therapy.
    Kim YB; Niloff JM
    Obstet Gynecol; 1993 Aug; 82(2):175-80. PubMed ID: 8336860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.